Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
January-2020 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2020 Volume 19 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer

  • Authors:
    • Sushant Kumar Das
    • Ya‑Yong Huang
    • Bing Li
    • Xiao Xuan Yu
    • Ru Hui Xiao
    • Han Feng Yang
  • View Affiliations / Copyright

    Affiliations: Department of Interventional Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China, Department of Radiology, Xuzhou City Center Hospital, Xuzhou, Jiangsu 221009, P.R. China
  • Pages: 1031-1041
    |
    Published online on: November 25, 2019
       https://doi.org/10.3892/ol.2019.11149
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to compare the safety and efficacy of cryoablation (CA) and microwave ablation (MWA) as treatments for non‑small cell lung cancer (NSCLC). Patients with stage IIIB or IV NSCLC treated with CA (n=45) or MWA (n=56) were enrolled in the present study. The primary endpoint was progression‑free survival (PFS); the secondary endpoints included overall survival (OS) time and adverse events (AEs). The median PFS times between the two groups were not significantly different (P=0.36): CA, 10 months [95% confidence interval (CI), 7.5‑12.4] vs. MWA, 11 months (95% CI, 9.5‑12.4). The OS times between the two groups were also not significantly different (P=0.07): CA, 27.5 months (95% CI, 22.8‑31.2 months) vs. MWA, 18 months (95% CI, 12.5‑23.5). For larger tumors (>3 cm), patients treated with MWA had significantly longer median PFS (P=0.04; MWA, 10.5 months vs. CA, 7.0 months) and OS times (P=0.04; MWA, 24.5 months vs. CA, 14.5 months) compared patients treated with CA. However, for smaller tumors (≤3 cm), median PFS (P=0.79; MWA, 11.0 months vs. CA, 13.0 months) and OS times (P=0.39; MWA, 30.0 months vs. CA, 26.5 months) between the two groups did not differ significantly. The incidence rates of AEs were similar in the two groups (P>0.05). The number of applicators, tumor size and length of the lung traversed by applicators were associated with a higher risk of pneumothorax and intra‑pulmonary hemorrhage in the two groups. Treatment with CA resulted in significantly less intraprocedural pain compared with treatment with MWA (P=0.001). Overall, the present study demonstrated that CA and MWA were comparably safe and effective procedures for the treatment of small tumors. However, treatment with MWA was superior compared with CA for the treatment of large tumors.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Wei Z, Ye X, Yang X, Huang G, Li W, Wang J and Han X: Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol. 32:4642015. View Article : Google Scholar : PubMed/NCBI

3 

Cancer Facts & Figures 2019. American Cancer Society's (ACS) publication; January. 2019, https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf

4 

Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern Cooperative Oncology Group, : Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, et al: Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 26:3543–3551. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Palussière J, Catena V and Buy X: Percutaneous thermal ablation of lung tumors-Radiofrequency, microwave and cryotherapy: Where are we going? Diagn Interv Imaging. 98:619–625. 2017. View Article : Google Scholar : PubMed/NCBI

7 

de Baere T, Tselikas L, Catena V, Buy X, Deschamps F and Palussière J: Percutaneous thermal ablation of primary lung cancer. Diagn Interv Imaging. 97:1019–1024. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Baisi A, De Simone M, Raveglia F and Cioffi U: Thermal ablation in the treatment of lung cancer: Present and future. Eur J Cardiothorac Surg. 43:683–686. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Simon CJ, Dupuy DE and Mayo-Smith WW: Microwave ablation: Principles and applications. Radiographics. 25 (Suppl 1):S69–S83. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Chi J, Ding M, Shi Y, Wang T, Cui D, Tang X, Li P and Zhai B: Comparison study of computed tomography-guided radiofrequency and microwave ablation for pulmonary tumors: A retrospective, case-controlled observational study. Thorac Cancer. 9:1241–1248. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Ierardi AM, Floridi C, Fontana F, Chini C, Giorlando F, Piacentino F, Brunese L, Pinotti G, Bacuzzi A and Carrafiello G: Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. Radiol Med. 118:949–961. 2013. View Article : Google Scholar : PubMed/NCBI

12 

van Tilborg AA, Scheffer HJ, de Jong MC, Vroomen LG, Nielsen K, van Kuijk C, van den Tol PM and Meijerink MR: MWA versus RFA for perivascular and peribiliary CRLM: A retrospective patient- and lesion-based analysis of two historical cohorts. Cardiovasc Intervent Radiol. 39:1438–1446. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Niu L, Xu K and Mu F: Cryosurgery for lung cancer. J Thorac Dis. 4:408–419. 2012.PubMed/NCBI

14 

Sonntag PD, Hinshaw JL, Lubner MG, Brace CL and Lee FT Jr: Thermal ablation of lung tumors. Surg Oncol Clin N Am. 20369–387. (ix)2011. View Article : Google Scholar : PubMed/NCBI

15 

de Baere T, Tselikas L, Gravel G and Deschamps F: Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies. Clin Radiol. 72:657–664. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Yamauchi Y, Izumi Y, Hashimoto K, Yashiro H, Inoue M, Nakatsuka S, Goto T, Anraku M, Ohtsuka T, Kohno M, et al: Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS One. 7:e332232012. View Article : Google Scholar : PubMed/NCBI

17 

Moore W, Talati R, Bhattacharji P and Bilfinger T: Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol. 26:312–319. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Goto T, Izumi Y, Nakatsuka S and Nomori H: Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer. Ann Thorac Surg. 94:e31–e33. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Kawamura M, Izumi Y, Tsukada N, Asakura K, Sugiura H, Yashiro H, Nakano K, Nakatsuka S, Kuribayashi S and Kobayashi K: Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 131:1007–1013. 2006. View Article : Google Scholar : PubMed/NCBI

20 

de Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, Suh R, Aoun HD and Callstrom M: Evaluating cryoablation of metastatic lung tumors in patients-safety and efficacy: The ECLIPSE trial-interim analysis at 1 year. J Thorac Oncol. 10:1468–1474. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Welch BT, Brinjikji W, Schmit GD, Callstrom MR, Kurup AN, Cloft HJ, Woodrum DA, Nichols FC and Atwell TD: A national analysis of the complications, cost, and mortality of percutaneous lung ablation. J Vasc Interv Radiol. 26:787–791. 2015. View Article : Google Scholar : PubMed/NCBI

22 

World Medical Association: World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 310:2191–2194. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Detterbeck FC, Boffa DJ, Kim AW and Tanoue LT: The eighth edition lung cancer stage classification. Chest. 151:193–203. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI

25 

Yang X, Ye X, Zheng A, Huang G, Ni X, Wang j, Han X, Li W and Wei Z: Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: Clinical evaluation of 47 cases. J Surg Oncol. 110:758–763. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Common terminology criteria for adverse events (version 4.0). https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/Archive/CTCAE_4.0_2009-05-29_QuickReference_8.5×11.pdfAugust 19–2018

27 

Wewes ME and Lowe NK: A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 13:227–236. 1990. View Article : Google Scholar : PubMed/NCBI

28 

Pusceddu C, Melis L, Sotgia B, Guerzoni D, Porcu A and Fancellu A: Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: A preliminary report. Oncol Lett. 18:659–666. 2019.PubMed/NCBI

29 

Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW and Dupuy DE: Microwave ablation of lung malignancies: Effectiveness, CT findings, and safety in 50 patients. Radiology. 247:871–879. 2008. View Article : Google Scholar : PubMed/NCBI

30 

Li C, Wang J, Shao JB, Zhu LM, Sun ZG and Zhang N: Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone. Thorac Cancer. 10:1628–1635. 2019. View Article : Google Scholar : PubMed/NCBI

31 

Zhang X, Tian J, Zhao L, Wu B, Kacher DS, Ma X, Liu S, Ren C and Xiao YY: CT-guided conformal cryoablation for peripheral NSCLC: Initial experience. Eur J Radiol. 8:3354–3362. 2012. View Article : Google Scholar

32 

Mahnken AH, König AM and Figiel JH: Current technique and application of percutaneous cryotherapy. Rofo. 190:836–846. 2018.(In English, German). View Article : Google Scholar : PubMed/NCBI

33 

Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr and Brace CL: Percutaneous tumor ablation tools: Microwave, radiofrequency, or cryoablation-what should you use and why? Radiographics. 34:1344–1362. 2014. View Article : Google Scholar : PubMed/NCBI

34 

Niu L, Chen J, Yao F, Zhou L, Zhang C, Wen W, Bi X, Hu Y, Piao X, Jiang F, et al: Percutaneous cryoablation for stage IV lung cancer: A retrospective analysis. Cryobiology. 67:151–155. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Niu L, Xu K, He W, GuoZ Q, Zhang SP, He TS and Zuo JS: Percutaneous Cryoablation for patients with advanced non-small cell lung cancer. Technol Cancer Res T. 6:451–452. 2007.

36 

Li Y, Feng H and Nie Z: The long-term effects and risk factors analysis in 253 cases advanced non-small cell lung cancer treated with percutaneous cryosurgery. Chin Clin Oncol. 15:346–349. 2010.

37 

Wei Z, Ye X, Yang X, Zheng A, Huang G, Li W, Ni X, Wang J and Han X: Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 38:135–142. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Li X, Zhao M, Wang J, Fan W, Li W, Pan T and Wu P: Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancer. AJR Am J Roentgenol. 201:1362–1367. 2013. View Article : Google Scholar : PubMed/NCBI

39 

McDevitt JL, Mouli SK, Nemcek AA, Lewandowski RJ, Salem R and Sato KT: Percutaneous cryoablation for the treatment of primary and metastatic lung tumors: Identification of risk factors for recurrence and major complications. J Vasc Interv Radiol. 27:1371–1379. 2016. View Article : Google Scholar : PubMed/NCBI

40 

Yashiro H, Nakatsuka S, Inoue M, Kawamura M, Tsukada N, Asakura K, Yamauchi Y, Hashimoto K and Kuribayashi S: Factors affecting local progression after percutaneous cryoablation of lung tumors. J Vasc Interv Radiol. 24:813–821. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Zemlyak A, Moore WH and Bilfinger TV: Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg. 211:68–72. 2010. View Article : Google Scholar : PubMed/NCBI

42 

Pusceddu C, Sotgia B, Fele RM and Melis L: CT-guided thin needles percutaneous cryoablation (PCA) in patients with primary and secondary lung tumors: A preliminary experience. Eur J Radiol. 82:e246–e253. 2013. View Article : Google Scholar : PubMed/NCBI

43 

Inoue M, Nakatsuka S, Yashiro H, Ito N, Izumi Y, Yamauchi Y, Hashimoto K, Asakura K, Tsukada N, Kawamura M, et al: Percutaneous cryoablation of lung tumors: Feasibility and safety. J Vasc Interv Radiol. 23:295–302. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H and Nie Z: Thoracic masses treated with percutaneous cryotherapy: Initial experience with more than 200 procedures. Radiology. 235:289–298. 2005. View Article : Google Scholar : PubMed/NCBI

45 

Chou HP, Chen CK, Shen SH, Sheu MH, Wu MH, Wu YC and Chang CY: Percutaneous cryoablation for inoperable malignant lung tumors: Midterm results. Cryobiology. 70:60–65. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Yang X, Ye X, Zhang L, Geng D, Du Z, Yu G, Ren H, Wang J, Huang G, Wei Z, et al: Microwave ablation for lung cancer patients with a single lung: Clinical evaluation of 11 cases. Thorac Cancer. 9:548–554. 2018. View Article : Google Scholar : PubMed/NCBI

47 

Steinke K, King J, Glenn D and Morris DL: Pulmonary hemorrhage during percutaneous radiofrequency ablation: A more frequent complication than assumed? Interact Cardiovasc Thorac Surg. 2:462–465. 2003. View Article : Google Scholar : PubMed/NCBI

48 

Nour-Eldin NE, Naguib NN, Mack M, Abskharon JE and Vogl TJ: Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol. 21:197–204. 2011. View Article : Google Scholar : PubMed/NCBI

49 

Hiraki T, Tajiri N, Mimura H, Yasui K, Gobara H, Mukai T, Hase S, Fujiwara H, Iguchi T, Sano Y, et al: Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: Incidence and risk factors. Radiology. 241:275–283. 2006. View Article : Google Scholar : PubMed/NCBI

50 

Welch BT, Brinjikji W, Schmit GD, Callstrom MR, Kurup AN, Cloft HJ, Woodrum DA, Nichols FC and Atwell TD: A national analysis of the complications, cost, and mortality of percutaneous lung ablation. J Vasc Interv Radiol. 26:787–791. 2015. View Article : Google Scholar : PubMed/NCBI

51 

Zheng A, Wang X, Yang X, Wang W, Huang G, Gai Y and Ye X: Major complications after lung microwave ablation: A single-center experience on 204 sessions. Ann Thorac Surg. 98:243–248. 2014. View Article : Google Scholar : PubMed/NCBI

52 

Lyons GR, Askin G and Pua BB: Clinical outcomes after pulmonary cryoablation with the use of a triple freeze protocol. J Vasc Interv Radiol. 29:714–721. 2018. View Article : Google Scholar : PubMed/NCBI

53 

Ye X, Fan W, Wang H, Wang J, Wang Z, Gu S, Feng W, Zhuang Y, Liu B, Li X, et al: Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition). J Cancer Res Ther. 14:730–744. 2018. View Article : Google Scholar : PubMed/NCBI

54 

Hiraki T, Gobara H, Fujiwara H, Ishii H, Tomita K, Uka M, Makimoto S and Kanazawa S: Lung cancer ablation: Complications. Semin Intervent Radiol. 30:169–175. 2013. View Article : Google Scholar : PubMed/NCBI

55 

Colak E, Tatlı S, ShynP B, Tuncalı K and Silverman SG: CT-guided percutaneous cryoablation of central lung tumors. Diagn Interv Radiol. 20:316–322. 2014. View Article : Google Scholar : PubMed/NCBI

56 

Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR and Solomon SB: Pain control requirements for percutaneous ablation of renal tumors: Cryoablation versus radiofrequency ablation-initial observations. Radiology. 237:366–370. 2005. View Article : Google Scholar : PubMed/NCBI

57 

Li CL: Effect of cooling on neuromuscular transmission in the rat. Am J Physiol. 194:200–206. 1958. View Article : Google Scholar : PubMed/NCBI

58 

Douglas WW and Malcolm LL: The effect of localized cooling on conduction in cat nerves. J Physiol. 130:53–71. 1955. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Das SK, Huang YY, Li B, Yu XX, Xiao RH and Yang HF: Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer . Oncol Lett 19: 1031-1041, 2020.
APA
Das, S.K., Huang, Y., Li, B., Yu, X.X., Xiao, R.H., & Yang, H.F. (2020). Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer . Oncology Letters, 19, 1031-1041. https://doi.org/10.3892/ol.2019.11149
MLA
Das, S. K., Huang, Y., Li, B., Yu, X. X., Xiao, R. H., Yang, H. F."Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer ". Oncology Letters 19.1 (2020): 1031-1041.
Chicago
Das, S. K., Huang, Y., Li, B., Yu, X. X., Xiao, R. H., Yang, H. F."Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer ". Oncology Letters 19, no. 1 (2020): 1031-1041. https://doi.org/10.3892/ol.2019.11149
Copy and paste a formatted citation
x
Spandidos Publications style
Das SK, Huang YY, Li B, Yu XX, Xiao RH and Yang HF: Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer . Oncol Lett 19: 1031-1041, 2020.
APA
Das, S.K., Huang, Y., Li, B., Yu, X.X., Xiao, R.H., & Yang, H.F. (2020). Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer . Oncology Letters, 19, 1031-1041. https://doi.org/10.3892/ol.2019.11149
MLA
Das, S. K., Huang, Y., Li, B., Yu, X. X., Xiao, R. H., Yang, H. F."Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer ". Oncology Letters 19.1 (2020): 1031-1041.
Chicago
Das, S. K., Huang, Y., Li, B., Yu, X. X., Xiao, R. H., Yang, H. F."Comparing cryoablation and microwave ablation for the treatment of patients with stage IIIB/IV non‑small cell lung cancer ". Oncology Letters 19, no. 1 (2020): 1031-1041. https://doi.org/10.3892/ol.2019.11149
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team